International Clinical Trial: Application Demonstration Program of Luvometinib for Pediatric and Adolescent Patients Aged 2 Years and Older with Symptomatic, Unresectable Plexiform Neurofibromas (PN) Associated with Neurofibromatosis Type 1 (NF1)(Demonstration project for the application of luvometinib in the treatment of neurofibromatosis type 1(rare disease))

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115360) titled 'Application Demonstration Program of Luvometinib for Pediatric and Adolescent Patients Aged 2 Years and Older with Symptomatic, Unresectable Plexiform Neurofibromas (PN) Associated with Neurofibromatosis Type 1 (NF1)(Demonstration project for the application of luvometinib in the treatment of neurofibromatosis type 1(rare disease))' on Dec. 25, 2025.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

Condition: Neurofibromatosis type 1

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enroll...